Cargando…

Bone and Soft-Tissue Sarcoma: A New Target for Telomerase-Specific Oncolytic Virotherapy

Adenovirus serotype 5 (Ad5) is widely and frequently used as a virus vector in cancer gene therapy and oncolytic virotherapy. Oncolytic virotherapy is a novel antitumor treatment for inducing lytic cell death in tumor cells without affecting normal cells. Based on the Ad5 genome, we have generated t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tazawa, Hiroshi, Hasei, Joe, Yano, Shuya, Kagawa, Shunsuke, Ozaki, Toshifumi, Fujiwara, Toshiyoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072448/ https://www.ncbi.nlm.nih.gov/pubmed/32085583 http://dx.doi.org/10.3390/cancers12020478

Ejemplares similares

Oncolytic virotherapy promotes radiosensitivity in soft tissue sarcoma by suppressing anti-apoptotic MCL1 expression
por: Omori, Toshinori, et al.
Publicado: (2021)

Role of zoledronic acid in oncolytic virotherapy: Promotion of antitumor effect and prevention of bone destruction
por: Yamakawa, Yasuaki, et al.
Publicado: (2017)

Real-Time Fluorescence Image-Guided Oncolytic Virotherapy for Precise Cancer Treatment
por: Yano, Shuya, et al.
Publicado: (2021)

Impact of Autophagy in Oncolytic Adenoviral Therapy for Cancer
por: Tazawa, Hiroshi, et al.
Publicado: (2017)

Multidisciplinary oncolytic virotherapy for gastrointestinal cancer
por: Fujiwara, Toshiyoshi
Publicado: (2019)

Elimination of MYCN-Amplified Neuroblastoma Cells by Telomerase-Targeted Oncolytic Virus via MYCN Suppression
por: Tanimoto, Terutaka, et al.
Publicado: (2020)

Liposome-encapsulated plasmid DNA of telomerase-specific oncolytic adenovirus with stealth effect on the immune system
por: Aoyama, Katsuyuki, et al.
Publicado: (2017)

The hTERT Promoter Enhances the Antitumor Activity of an Oncolytic Adenovirus under a Hypoxic Microenvironment
por: Hashimoto, Yuuri, et al.
Publicado: (2012)

Targeting tumors with a killer-reporter adenovirus for curative fluorescence-guided surgery of soft-tissue sarcoma
por: Yano, Shuya, et al.
Publicado: (2015)

FUCCI Real-Time Cell-Cycle Imaging as a Guide for Designing Improved Cancer Therapy: A Review of Innovative Strategies to Target Quiescent Chemo-Resistant Cancer Cells
por: Yano, Shuya, et al.
Publicado: (2020)

Ablation of MCL1 expression by virally induced microRNA-29 reverses chemoresistance in human osteosarcomas
por: Osaki, Shuhei, et al.
Publicado: (2016)

Immunotherapy for Bone and Soft Tissue Sarcomas
por: Uehara, Takenori, et al.
Publicado: (2015)

ONCOLYTIC VIROTHERAPY
por: Russell, Stephen J, et al.
Publicado: (2012)

Efficacy of a Cell-Cycle Decoying Killer Adenovirus on 3-D Gelfoam(®)-Histoculture and Tumor-Sphere Models of Chemo-Resistant Stomach Carcinomatosis Visualized by FUCCI Imaging
por: Yano, Shuya, et al.
Publicado: (2016)

Tumor-targeting adenovirus OBP-401 inhibits primary and metastatic tumor growth of triple-negative breast cancer in orthotopic nude-mouse models
por: Yano, Shuya, et al.
Publicado: (2016)

p53-armed oncolytic adenovirus induces autophagy and apoptosis in KRAS and BRAF-mutant colorectal cancer cells
por: Tamura, Shuta, et al.
Publicado: (2023)

Advances in oncolytic virotherapy
por: Russell, Stephen J., et al.
Publicado: (2022)

Editorial: Oncolytic virotherapy
por: Al-Shammari, Ahmed Majeed, et al.
Publicado: (2023)

Boosting Replication and Penetration of Oncolytic Adenovirus by Paclitaxel Eradicate Peritoneal Metastasis of Gastric Cancer
por: Ishikawa, Wataru, et al.
Publicado: (2020)

Oncolytic virotherapy with human telomerase reverse transcriptase promoter regulation enhances cytotoxic effects against gastric cancer
por: Kato, Tomoya, et al.
Publicado: (2021)

Oncolytic virotherapy with human telomerase reverse transcriptase promoter regulation enhances cytotoxic effects against gastric cancer
por: Kato, Tomoya, et al.
Publicado: (2021)

Role of Tumor-Associated Macrophages in Sarcomas
por: Fujiwara, Tomohiro, et al.
Publicado: (2021)

Fluorescence-guided surgery of a highly-metastatic variant of human triple-negative breast cancer targeted with a cancer-specific GFP adenovirus prevents recurrence
por: Yano, Shuya, et al.
Publicado: (2016)

Oncolytic Virotherapy for Hematological Malignancies
por: Bais, Swarna, et al.
Publicado: (2012)

Oncolytic virotherapy – in vivo veritas
por: Kemler, Iris, et al.
Publicado: (2018)

Oncolytic Virotherapy in Glioma Tumors
por: Rius-Rocabert, Sergio, et al.
Publicado: (2020)

Delivery and Biosafety of Oncolytic Virotherapy
por: Li, Lizhi, et al.
Publicado: (2020)

Oncolytic Virotherapy with Myxoma Virus
por: Rahman, Masmudur M., et al.
Publicado: (2020)

Syncytia Formation in Oncolytic Virotherapy
por: Burton, Chase, et al.
Publicado: (2019)

Progress of oncolytic virotherapy for neuroblastoma
por: Chen, Xiao-Tong, et al.
Publicado: (2022)

Absence of Telomerase Activity in Malignant Bone Tumors and Soft-Tissue Sarcomas
por: Lauer, Nina K., et al.
Publicado: (2002)

Improved Resection and Outcome of Colon-Cancer Liver Metastasis with Fluorescence-Guided Surgery Using In Situ GFP Labeling with a Telomerase-Dependent Adenovirus in an Orthotopic Mouse Model
por: Yano, Shuya, et al.
Publicado: (2016)

Isolated limb perfusion with biochemotherapy and oncolytic virotherapy combines with radiotherapy and surgery to overcome treatment resistance in an animal model of extremity soft tissue sarcoma
por: Wilkinson, Michelle J., et al.
Publicado: (2016)

Oncolytic Virotherapy of Canine and Feline Cancer
por: Gentschev, Ivaylo, et al.
Publicado: (2014)

Oncolytic virotherapy for advanced liver tumours
por: Chang, Ju-Fang, et al.
Publicado: (2009)

The Practical Consideration of Poliovirus as an Oncolytic Virotherapy
por: Denniston, Elizabeth, et al.
Publicado: (2016)

Measles virus: Background and oncolytic virotherapy
por: Bhattacharjee, Sankhajit, et al.
Publicado: (2018)

Implications of MicroRNAs in Oncolytic Virotherapy
por: Bofill-De Ros, Xavier, et al.
Publicado: (2017)

Combination strategies enhance oncolytic virotherapy
por: Friedman, Gregory K., et al.
Publicado: (2017)

Oncolytic Virotherapy for Breast Cancer Treatment
por: O’Bryan, Samia M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_loid86c4rk6uqvqui1nr6r0vds